163 related articles for article (PubMed ID: 28405956)
21. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
24. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.
Solberg LI; Hurley JS; Roberts MH; Nelson WW; Frost FJ; Crain AL; Gunter MJ; Young LR
Am J Manag Care; 2004 Nov; 10(11 Pt 1):753-9. PubMed ID: 15623265
[TBL] [Abstract][Full Text] [Related]
25. Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean.
Dookeeram D; Bidaisee S; Paul JF; Nunes P; Robertson P; Maharaj VR; Sammy I
Int J Clin Pharm; 2017 Oct; 39(5):1119-1127. PubMed ID: 28795285
[TBL] [Abstract][Full Text] [Related]
26. Drug-drug interactions in a cohort of hospitalized elderly patients.
Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
[TBL] [Abstract][Full Text] [Related]
27. Identifying and Communicating Clinically Meaningful Drug-Drug Interactions.
Nelson SD; LaFleur J; Hunter E; Archer M; Steinvoort C; Maden C; Oderda GM
J Pharm Pract; 2016 Apr; 29(2):110-5. PubMed ID: 25107417
[TBL] [Abstract][Full Text] [Related]
28. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors.
Oliveira RF; Oliveira AI; Cruz AS; Ribeiro O; Afreixo V; Pimentel F
BMC Geriatr; 2024 Jun; 24(1):557. PubMed ID: 38918696
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.
van Heerden JA; Burger JR; Gerber JJ; Vlahović-Palčevski V
Int J Pharm Pract; 2018 Apr; 26(2):156-164. PubMed ID: 28665037
[TBL] [Abstract][Full Text] [Related]
31. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
33. Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register.
Astrand E; Astrand B; Antonov K; Petersson G
Eur J Clin Pharmacol; 2007 Sep; 63(9):851-9. PubMed ID: 17598096
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
Su BB; Ma JX; Song W; Yuan J; Dong XY; Wan J
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1983-1987. PubMed ID: 32629601
[No Abstract] [Full Text] [Related]
35. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan Á; McAllister K; Bellón JM; Gibbons S; Balsalobre P; Pérez-Latorre L; Benedí J; Marzolini C; Aranguren-Oyarzábal A; Khoo S; Calvo-Alcántara MJ; Berenguer J
Clin Infect Dis; 2020 Jul; 71(2):353-362. PubMed ID: 31428770
[TBL] [Abstract][Full Text] [Related]
36. Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.
Raschi E; Piccinni C; Signoretta V; Lionello L; Bonezzi S; Delfino M; Di Candia L; Di Castri L; Pieraccini F; Carati D; Poluzzi E; De Ponti F;
Br J Clin Pharmacol; 2015 Dec; 80(6):1411-20. PubMed ID: 26303150
[TBL] [Abstract][Full Text] [Related]
37. Concordance of severity ratings provided in four drug interaction compendia.
Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
[TBL] [Abstract][Full Text] [Related]
39. Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study.
Galai E; Scotti L; Gilardetti M; Ucciero A; Ferrante D; Poluzzi E; Genazzani AA; Barone-Adesi F
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742605
[TBL] [Abstract][Full Text] [Related]
40. Polypharmacy-induced drug-drug interactions; threats to patient safety.
Sharifi H; Hasanloei MA; Mahmoudi J
Drug Res (Stuttg); 2014 Dec; 64(12):633-7. PubMed ID: 24500732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
